Semaglutide 0.25 mg injection

Mechanism

GLP-1 receptor agonist; daily or weekly (liraglutide; dulaglutide; semaglutide; exenatide extended release; albiglutide; efpeglenatide; loxenatide; taspoglutide and others)

Trials

0

Participants in these arms

0

Related

• All doses pooled: Semaglutide injection
• Semaglutide 1.0 mg subcutaneous once weekly
• Semaglutide maximum tolerated dose injection once weekly
• Semaglutide 2.4 mg subcutaneous once weekly
• Semaglutide 0.5 mg subcutaneous once weekly
• Semaglutide 0.5 mg injection
• Semaglutide flexible dose injection once weekly
• Semaglutide 0.4 mg injection once daily
• Semaglutide 0.1 mg injection once daily
• Semaglutide 0.2 mg injection once daily
• Semaglutide 2.0 mg subcutaneous once weekly
• Semaglutide 1.5 mg injection once weekly
• Semaglutide 8 mg injection once weekly
• Semaglutide 16 mg injection once weekly
• Semaglutide 0.1072 mg injection
• Semaglutide 1.7 mg injection once weekly
• Semaglutide flexible dose injection once weekly
• Semaglutide 0.05 mg injection once daily
• Semaglutide 0.3 mg injection once daily
• Semaglutide flexible dose injection once weekly
• Semaglutide 2.4 mg injection